Dysfunctional nitric oxide signalling increases risk of myocardial infarction.
about
Association claims in the sequencing eraThe impact of genome-wide association studies on the pathophysiology and therapy of cardiovascular diseaseGenetics of coronary artery disease and myocardial infarctionExtending the translational potential of targeting NO/cGMP-regulated pathways in the CVSGenetic Architecture of Atherosclerosis in Mice: A Systems Genetics Analysis of Common Inbred StrainsPrediction of Causal Candidate Genes in Coronary Artery Disease LociSystems Medicine as an Emerging Tool for Cardiovascular GeneticsAsymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studiesA comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery diseaseStroke Risk Factors, Genetics, and Prevention.Functional Characterization of the GUCY1A3 Coronary Artery Disease Risk Locus.Low-frequency and common genetic variation in ischemic stroke: The METASTROKE collaboration.Inherited dysfunctional nitric oxide signaling and the pathobiology of atherothrombotic disease.Hypertension reduces soluble guanylyl cyclase expression in the mouse aorta via the Notch signaling pathwayMutation in KERA identified by linkage analysis and targeted resequencing in a pedigree with premature atherosclerosis.Sensitivity to Sevoflurane anesthesia is decreased in mice with a congenital deletion of Guanylyl Cyclase-1 alpha.The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies.New Developments in Platelet Cyclic Nucleotide Signalling: Therapeutic Implications.Genetics of coronary artery disease: discovery, biology and clinical translation.Whole-exome sequencing in an extended family with myocardial infarction unmasks familial hypercholesterolemia.Inactivating mutations in NPC1L1 and protection from coronary heart diseaseSystematic cell-based phenotyping of missense alleles empowers rare variant association studies: a case for LDLR and myocardial infarction.Hemoglobin βCys93 is essential for cardiovascular function and integrated response to hypoxia.Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in mice.Hemoglobin induced NO/cGMP suppression Deteriorate Microcirculation via Pericyte Phenotype Transformation after Subarachnoid Hemorrhage in RatsA rare variant in MCF2L identified using exclusion linkage in a pedigree with premature atherosclerosisWhole-exome sequencing for the discovery of rare genetic variants that protect from coronary artery disease.The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals.Unbalanced Oxidant-Antioxidant Status: A Potential Therapeutic Target for Coronary Chronic Total Occlusion in Very Old Patients.Genetic testing in cardiovascular diseases.New therapies for coronary artery disease: genetics provides a blueprint.cGMP: transition from bench to bedside: a report of the 6th International Conference on cGMP Generators, Effectors and Therapeutic Implications.Next generation sequencing and the future of genetic diagnosis.Shared genetic aetiology of coronary artery disease and atherosclerotic stroke - 2015.Role of sGC-dependent NO signalling and myocardial infarction risk.Epidemiology in Germany-general development and personal experience.Molecular genetics of coronary artery disease.Glucose Homeostasis and Cardiovascular Alterations in Diabetes.NGS Technologies as a Turning Point in Rare Disease Research , Diagnosis and Treatment.Clinical relevance of cyclic GMP modulators: A translational success story of network pharmacology.
P2860
Q24273315-1E8023DA-4002-4F3A-B4FB-6CB55E0306CEQ26748869-31F6A5B4-EC98-4FB9-A103-EBE02ACC4974Q26769994-6A56FD1D-D444-47AE-9798-3CEB88CF43FBQ27021649-3D920F53-8F86-43B2-92F2-44E86CE89315Q27309881-0BC50C95-9D43-4DB7-8C1C-C283B8405D85Q27342192-24240537-6E21-4910-9D52-93AC6C108C68Q28069197-22EC47A0-1640-47CA-BD23-AD18854BC80EQ28087272-08DEBF0C-D9F7-4EEB-919B-EE917136B5C4Q28267020-5A8E5D28-A4AB-4015-881C-5415880B7BF3Q30238633-0F932C8E-8BF2-44CB-B3CC-9CDBD8CF5ECFQ30252419-41CBCA7F-0AB9-4BE2-B3A1-2C1D229BD685Q30356365-9C652609-375D-40A1-8BCE-66E05637030BQ33642069-5935DEF7-D0B6-49FE-8F34-EB878DCE9726Q33683635-03BE370B-74B6-404C-A2B0-E45A10CCC085Q33690049-5135E104-BAF4-4E4C-A7F0-D4205F222E39Q33801187-8861C8F9-41B4-48D1-9FB5-3BE4B0D4AB2DQ34042836-08792CFB-5114-4B79-8557-C842696A44C5Q34532327-CC420AD4-ED60-4C00-A695-D088B2AA789CQ34553141-97C8D91D-481B-4872-AB5B-F65C8C813C7BQ34569742-361AE48E-DF89-4103-B98B-20FFB9F58DC7Q35105445-56CD1DC0-2227-4C89-8550-89D3E827E9F3Q35538234-F0E78A59-82E8-488D-9B12-C1BC44FD479AQ35644835-B234B0ED-0F8A-4AA6-A4BB-6585454BE1C8Q36424922-46F8718D-68CE-4532-8D01-B2E9EDA70C91Q36615945-9031C8A3-6249-4CE9-BB07-D2CB32D602DBQ36695830-37B117CB-4521-4334-B9B7-10E50A528B7DQ36832490-7C4D0D38-7140-4A77-9D97-6B4E9CCB1C1AQ37297746-B6961D5B-6EFB-4EC9-8B94-E9F8042631B6Q37504067-B4F15FB6-F0F1-4696-ABF7-C62BB9FCDF52Q38203394-AD49F077-938C-4744-9319-20ADCB5CCB84Q38217732-477A1FF6-8A2B-48A1-A916-ACFFE81341C9Q38220091-04356ADE-5E9D-4817-9570-4CE5B1E385CEQ38232771-7C0FB608-7726-4617-8C5F-84F14B625403Q38359111-9846B765-0868-4C81-811F-697CA46FB654Q38367012-861AD448-584B-4653-9545-86FB1DD33A03Q38368774-37A06AC8-CA03-414F-9F32-1C5638B45537Q38541814-1DB9F636-C3DA-4419-9272-492EBC4248C8Q38596700-ABF3BFCC-3192-4693-90FD-1FECA489CF87Q38655437-139D552E-F661-4462-BD0D-5B10A0EC3DA2Q38696148-6515535E-0A64-4D6C-BDDB-B675F739157B
P2860
Dysfunctional nitric oxide signalling increases risk of myocardial infarction.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Dysfunctional nitric oxide signalling increases risk of myocardial infarction.
@en
Dysfunctional nitric oxide signalling increases risk of myocardial infarction.
@en-gb
Dysfunctional nitric oxide signalling increases risk of myocardial infarction.
@nl
type
label
Dysfunctional nitric oxide signalling increases risk of myocardial infarction.
@en
Dysfunctional nitric oxide signalling increases risk of myocardial infarction.
@en-gb
Dysfunctional nitric oxide signalling increases risk of myocardial infarction.
@nl
prefLabel
Dysfunctional nitric oxide signalling increases risk of myocardial infarction.
@en
Dysfunctional nitric oxide signalling increases risk of myocardial infarction.
@en-gb
Dysfunctional nitric oxide signalling increases risk of myocardial infarction.
@nl
P2093
P2860
P50
P356
P1433
P1476
Dysfunctional nitric oxide signalling increases risk of myocardial infarction.
@en
P2093
Anja Medack
Anthony J Balmforth
CARDIoGRAM
Christian Hengstenberg
Christina Willenborg
Christof Burgdorf
Diana Braunholz
Doris Koesling
Elisabeth Graf
Evanthia Mergia
P2860
P2888
P304
P356
10.1038/NATURE12722
P407
P50
P577
2013-11-10T00:00:00Z
P6179
1012295459